2006 Faculty Awards: Boyce Wins Established Entrepreneur Award
Burn patients and others with chronic skin wounds will benefit from a new medical product developed by Steven Boyce.
Dr. Boyce developed a cultured skin substitute, tradenamed PermaDerm, which allows damaged skin to regenerate with the use of less donated skin, thus reducing the need for skin grafts from other parts of the patients body.
PermaDerm combines a biodegradeable fabric made from collagen with the patients skin cells in a graft that allows skin to regrow. One advantage to his discovery is that it has been used successfully with large burns even patients who suffer burns over as much as 90 percent of their bodies.
Boyce holds six U.S. patents in tissue engineering and recently sold his start-up company, Cutanogen, to Cambrex Corporation. Boyce has served on the UC faculty since 1989.
Related Stories
Hoxworth Blood Center's Research Division shines with 2023...
April 22, 2024
Hoxworth Blood Center's Research Division Shines with 2023 National and International Publications: A Milestone Year in Transfusion Medicine.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.
UC's record graduating class prepares for next chapter
April 22, 2024
UC will confer degrees to 7,521 degrees to 7,391 students. (Some students are earning multiple degrees.) Both represent new records at UC for a single graduating class dating back two centuries.